SIDE EFFECTS MONITORING OF AMINOGLYCOSIDE ANTIBIOTIC IN HOSPITALIZED PATIENTS
Objective: The aim of this study was to monitor the side effects in patients who received aminoglycoside antibiotics at the inpatient service of
Fatmawati Hospital from March to May 2017.
Methods: This was an observational study based on data collected through patient interview, prescribing information, and medical records. Data
were collected on all inpatients treated with aminoglycosides during the study period (total sampling method). The Naranjo algorithm was used to
assess the causality of the observed effects.
Results: The data from 33 patients were evaluated, among whom 14 (42.4%) developed nephrotoxicity and 5 (15.2%) had ototoxicity. Based on the
Naranjo algorithm analysis, the five cases of ototoxicity were categorized as probable drug side effects. No correlation was found between any of the
side effects and either age (p=0.726) or sex (p=0.620).
Conclusion: In this evaluation of the side effects attributable to aminoglycoside antibiotics in hospitalized patients, nephrotoxicity was the most
common, followed by ototoxicity. The latter was deemed probable drug-related side effects based on the Naranjo algorithm. Of the other side effects,
twice as many were considered probable as those thought to be possible drug side effects. Neither age nor sex was significantly related to the adverse
effects secondary to gentamicin or amikacin.
Pharmacological Basis of Therapeutics. 12th ed. New York: McGraw
Hill Medical Publishing Division; 2013.
2. Kent A, Turner MA, Sharland M, Heath PT. Aminoglycoside toxicity
in neonates: Something to worry about? Expert Rev Anti Infect Ther
3. Gattani SG, Patil AB, Kushare SS. Pharmacoeconomics: A review.
Asian J Pharm Clin Res 2009;2:12-26.
4. Ramesh L, Sangeeta SS, Hussainy SR. Analysis of antimicrobial
prescriptions in pediatric patients in a teaching hospital. Asian J Pharm
Clin Res 2012;5:124-8.
5. Alakhali KM, Alzomor AK, Alavudeen SS, Khan NA Dawbaa SA.
Bacterial resistance of antibiotics used in urinary tract infection. Asian
J Pharm Clin Res 2013;6:87-91.
6. Andrajati R, Tilaqza A, Supardi S. Factors related to rational antibiotic
prescriptions in community health centers in Depok city, Indonesia.
J Infect Public Health 2017;10:41-8.
7. Begg EJ, Barclay ML, Kirkpatrick CM. The therapeutic monitoring of
antimicrobial agents. Br J Clin Pharmacol 2001;52 Suppl 1:35S-43.
8. Ambardekar AP, Schwartz AJ. Essential clinical anesthesia. Anesth
9. National Agency of Drug and Food Control, Republic of Indonesia.
Guidelines for Monitoring Side Effects of Medicines for Health
Personnel. Jakarta: BPOM; 2012. p. 1-35.
10. Overview A, Given C, Risk N, Moore AR. Aminoglycosides in Septic
Shock. Switzerland: Springer; 2013. p. 217-30.
11. Pogue JM, Brian A, Kaye KS. Aminoglycoside use in intensive
care units and aminoglycoside nephrotoxicity. Antimicrob Agents
12. Xie J, Talaska AE, Schacht J. New developments in aminoglycoside
therapy and ototoxicity. Hear Res 2011;281:28-37.
13. Bryson ML, Ipema HJ. Book review: Drug information handbook:
A comprehensive resource for all clinicians and healthcare professionals.
Ann Pharm 2013;47:1235-8.
14. Collins AA, Barnett LC, Smith PS. Clinical Drug Therapy - Rationales
for Nursing Practice. United State: Lippincott Williams and Wilkins;
2009. p. 1168.
15. Erol S. Aminoglycoside-induced ototoxicity. Curr Pharm Des
16. Sweileh WM. Gender differences in aminoglycoside induced
nephrotoxicity: A prospective, hospital-based study. Curr Clin Pharmacol